(VIANEWS) - ProLogis (PLD), Core Laboratories N.V. (CLB), CoStar Group (CSGP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ProLogis (PLD)
33.1% sales growth and 11.1% return on equity
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.
Earnings per Share
ProLogis' trailing twelve-month EPS is $1.82.
PE Ratio
ProLogis' trailing 12-month price-earnings ratio is 62.41. The purchaser of the shares is therefore investing $62.41 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 11.1%.2. Core Laboratories N.V. (CLB)
14.8% sales growth and 9.15% return on equity
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment offers services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amstelveen, the Netherlands.
Earnings per Share
Core Laboratories N.V.'s trailing twelve-month EPS is $0.42.
PE Ratio
Core Laboratories N.V.'s trailing 12 months earnings to price ratio is 46.48. The purchaser of the shares is therefore investing $46.48 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 9.15%.Annual Top and Bottom Value
Core Laboratories N.V. stock was valued at $19.66 as of 19:22 EST. This is way lower than its 52 week high of $35.83, and much higher than its 52 week low of $13.19.
Moving Average
Core Laboratories N.V.'s worth is under its 50-day moving average of $19.97 and under its 200-day moving average of $21.65.3. CoStar Group (CSGP)
13.6% sales growth and 5.49% return on equity
CoStar Group, Inc. offers information, analytics, online marketplace services, and other related professions to the residential, commercial, hotel, and hospitality industries. It is located in the United States, Canada, Europe, Asia Pacific, Latin America, Canada, and the United States. CoStar Property, which provides an inventory of commercial, residential, multi-family, hotel, student housing, and retail properties; CoStar COMPS is a database that compares real estate transactions in the United States; CoStar Market Analytics allows you to see and analyze aggregated submarket and market trends. CoStar Tenant provides information about tenants and offers online prospecting. CoStar Risk Analytics and CoStar Investment are also offered by the company. In addition, it offers apartment marketing sites, such as ApartmentFinder.com, ForRent.com, ApartmentHomeLiving.com, WestsideRentals.com, AFTER55.com, CorporateHousing.com, ForRentUniversity.com, Apartamentos.com, and Off Campus Partners; LoopNet Premium Lister; LoopNet Diamond, Platinum, and Gold Ads; LandsofAmerica.com, LandAndFarm.com, and LandWatch.com for rural land for-sale; BizBuySell.com, BizQuest.com, and FindaFranchise.com for operating businesses and franchises for-sale; Ten-X, an online auction platform for commercial real estate; and HomeSnap, an online and mobile software platform, as well as Homes.com, a homes for sale listings site. CoStar Group, Inc., was established in 1987. It is located in Washington, DC.
Earnings Per Share
As for profitability, CoStar Group has a trailing twelve months EPS of $5.86.
PE Ratio
CoStar Group has a trailing twelve months price to earnings ratio of 13.1. Meaning, the purchaser of the share is investing $13.1 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.49%.4. Stryker Corp (SYK)
7.3% sales growth and 14.1% return on equity
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Earnings per Share
Stryker Corp's trailing 12 months EPS is $3.69.
PE Ratio
Stryker Corp's trailing 12-month price-to-earnings ratio is 66.26. The purchaser of the shares is therefore investing $66.26 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 14.1%.